about
HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?Sonoelastography--a useful adjunct for parotid gland ultrasound assessment in patients suffering from chronic inflammation.Shear wave elastography: a new noninvasive tool to assess the intensity of fibrosis of irradiated salivary glands in head and neck cancer patientsMoving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.Narrow-band imaging (NBI) for improving the assessment of vocal fold leukoplakia and overcoming the umbrella effect.Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumorsFrequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.Evaluation of outcomes after reoperative neck dissection due to thyroid cancerValue of open horizontal glottectomy in the treatment for T1b glottic cancer with anterior commissure involvement.The Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesGlobal miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal CarcinomaAttempt to improve functional outcomes in supracricoid laryngectomy in T2b and T3 glottic cancers.Multicenter experiences in temporal bone cancer surgery based on 89 casesAlgorithm changes in treatment of submandibular gland sialolithiasis.Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers.Comparison of positron emission tomography/computed tomography imaging and ultrasound in surveillance of head and neck cancer - The 3-year experience of the ENT Department in Poznan.Variable course of progression of oral cavity and oropharyngeal carcinoma in young adults.Otologic symptoms as initial manifestation of wegener granulomatosis: diagnostic dilemma.Radiotherapy induced xerostomia: mechanisms, diagnostics, prevention and treatment--evidence based up to 2013.HPV vaccination in head and neck HPV-related pathologies.The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck.Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma.Assessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms.What more can be done to popularize phonosurgical ideas in everyday handling of vocal folds?The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma.Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.Clinical outcomes of treatment of sinonasal inverted papillomas (IPs) depending on the surgical technique and learning curve.Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.Genetic signature and profiling of head and neck cancer: where do we stand?The incidence of laryngeal cancer in Europe with special regard to Poland in last 2 decades.The efficacy of submucosal corticosteroid injection and dilatation in subglottic stenosis of different aetiology.The analysis of expression of p16 protein in group of 53 patients treated for sinonasal inverted papilloma.Adverse histopathological findings in glottic cancer with anterior commissure involvement.Age of onset of recurrent respiratory papillomatosis: a distribution analysis.Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?Letter to the Editor of European Archives of Otorhinolaryngology about a paper "Classification of parotidectomies: a proposal of the European Salivary Gland Society" by Quer et al.[Laryngeal actinomycosis - a case report and the review of the literature].
P50
Q28269286-AC487193-EE13-489A-9968-2E5DC4B102C4Q30424509-763B7E9F-28A6-4C18-B2F2-B49A28243DA9Q30431189-064D7921-9273-40B8-B240-F6153B85B0EAQ31043365-9202CCF0-C645-4182-BFC9-B0953248C3EDQ33853720-18C60970-A75B-4CC7-8687-52E98C059157Q33881913-AC917309-0872-4D3E-AB8F-5F2C7E0BB04DQ33905652-90E3BDCA-CA94-4737-BCDB-31732E867596Q34154176-D3A75D01-E921-4353-98EB-ED56F8420D87Q34226796-849B4E19-8C2A-4100-BC38-D4E5A7A3C43AQ34789041-BCB055A3-3564-4F85-B455-532BCF7DB211Q35821324-6F092BFF-36C7-47DF-9AF3-6EB326F2B5B9Q35838231-64F6A5C4-E7E8-4635-83CE-A00E06D3FAF4Q35875417-7BF21CC9-CBF6-4CE4-8C53-EE713A0B281BQ35983375-A222E50C-0248-4C0A-BCAE-5550849EEA45Q36287451-2CC8B444-1B96-4985-98E1-610C61C7421DQ36892800-CD6262FC-33B0-4B6C-8EAB-B9C22789C91EQ37208190-98B365A5-905E-4FB6-A33C-A7F5524D6646Q37376899-F364B107-7C51-457C-9AAB-224BF229E684Q37392480-C5061115-2F6C-4E5A-98FF-1F3E6D67A512Q37601962-9A88E7B1-43B9-4BC1-9016-16A700AECDE2Q37897127-8FF03D75-AE41-4B19-8559-2650F04DC020Q38184047-4AD63522-05A4-4CAE-B922-5BE76C6CA0CBQ38224976-4916439D-68C0-4FDF-97A0-12DA76F76E62Q38261990-9AE51571-0803-450D-8CCA-EDBF60CA5CA6Q38263740-86CD853B-CE81-4D5A-8AED-AA0A222F68C5Q38377890-1C9F23F7-23B3-41DE-8577-F51BCB0A862FQ38628428-E0CABA70-2E09-4806-8162-D69B6E4A8360Q38634596-C83A327F-E0BE-4604-B830-35DE8ED135DAQ38710424-C1FD5CD8-D0C1-41DD-BA69-A59F9D410B88Q38796419-0190F11E-623B-44C3-9E8C-29C89538A238Q39001461-5A0B28FA-4783-4522-B00B-7DC4EA2ABF7DQ39111769-B707320B-A0D8-4FCF-B7D6-0D09DB3E7220Q39624849-D95C400C-E861-458E-A37C-52437B7EC822Q39819424-BD2A8647-69D6-44B3-B380-8E3AFA517C02Q40223424-C86723C4-5BF0-4A15-83B2-A7D05BF04943Q41187157-4C9D153A-E66A-442A-AB44-C760CBD86890Q41229346-D8ABDCDA-F9D5-4321-A0F8-8DB0EEF13AB4Q41507150-F27BF811-8FA6-47F9-BB47-2BA1D9012C56Q42397205-0D132DA8-E5FC-43B5-9A5B-9B5C3F9D2413Q43662148-E9974B37-2CF3-470D-BE62-2D1BA575F812
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
M Wierzbicka
@ast
M Wierzbicka
@en
M Wierzbicka
@es
M Wierzbicka
@nl
type
label
M Wierzbicka
@ast
M Wierzbicka
@en
M Wierzbicka
@es
M Wierzbicka
@nl
prefLabel
M Wierzbicka
@ast
M Wierzbicka
@en
M Wierzbicka
@es
M Wierzbicka
@nl
P106
P1153
7004893417
P31
P496
0000-0003-0006-6352